CLOBETASOL EMOLLIENT

Add Drug

Prices & Coupons

RITE AID PHARMACY 01225

534 Hudson Street
New York NY 10014
(646)486-1048

$21.36

Get Your Coupon 9 more results found for RITE AID CORPORATION

COSTCO PHARMACY #1062

517 E 117 Th St
New York NY 10035
(212)896-5882

$29.86

Get Your Coupon 1 more results found for COSTCO PHARMACIES

ACME PHARMACY #1083

125 18 Th St
Jersey City NJ 07310
(201)418-0585

$33.94

Get Your Coupon 1 more results found for NEW ALBERTSONS LP

COMMUNITY, A WALGREENS PHARMACY #16463

29 W 116 Th St
New York NY 10026
(212)519-8346

$34.94

Get Your Coupon 104 more results found for WALGREENS DRUG STORE

OPTUM PHARMACY 706 INC

3030 47 Th Avenue
Long Island City NY 11101
(855)427-4682

$34.94

Get Your Coupon

133RD STREET PHARMACY INC

1473 Amsterdam Ave
New York NY 10027
(212)491-4911

$41.83

Get Your Coupon

AHF PHARMACY

475 Atlantic Ave
Brooklyn NY 11217
(718)637-2970

$41.83

Get Your Coupon 1 more results found for AIDS HEALTHCARE FOUNDATION

AHF PHARMACY

2307 Astoria Blvd
Astoria NY 11102
(718)545-2550

$41.83

Get Your Coupon

ALICE RX CORP

231 S 3 Rd St
Brooklyn NY 11211
(718)502-6969

$41.83

Get Your Coupon 24 more results found for PHARMACY FIRST

DANNY'S PHARMACY II

110 W End Ave
New York NY 10023
(212)362-0000

$41.83

Get Your Coupon

NORTH HUDSON COMMUNITY PHARMACY

5301 Broadway
West New York NJ 07093
(201)520-9364

$41.83

Get Your Coupon

PILL CLOUD RX

6010 Queens Blvd
Woodside NY 11377
(718)255-6015

$41.83

Get Your Coupon

A.M. PHARMACY II, INC

223 Grand Street
New York NY 10013
(212)226-8832

$41.93

Get Your Coupon 27 more results found for ALIGNRX (783)

HUDSON PHARMACY

65 08 Roosevelt Avenue
Woodside NY 11377
(347)448-6965

$41.93

Get Your Coupon

1699 FANCY PHARMACY INC

132 Allen St
New York NY 10002
(212)529-4532

$42.43

Get Your Coupon 77 more results found for ELEVATE PROVIDER NETWORK 904

26 PHARMACY

26 East Broadway
New York NY 10002
(212)925-3838

$42.43

Get Your Coupon 228 more results found for LEADER DRUG STORES INC

AVENUE C PHARMACY

178 Ave C
New York NY 10009
(212)228-0764

$42.43

Get Your Coupon 32 more results found for EPIC PHARMACY NETWORK INC

MOUNT SINAI PHARMACY - CHELSEA

275 7 Th Avenue 12 Th Floor
New York NY 10001
(212)604-1780

$42.43

Get Your Coupon 6 more results found for ELEVATE PROVIDER NETWORK 959

QUICK RX

909 Columbus Ave
New York NY 10025
(212)222-6388

$42.43

Get Your Coupon 1 more results found for MHA LONG TERM CARE NETWORK

137 MOTT PHARMACY, INC.

137 Mott St
New York NY 10013
(646)669-8220

$42.93

Get Your Coupon 42 more results found for HEALTH MART ATLAS 605

79TH STREET PHARMACY

215 W 79 Th St
New York NY 10024
(646)370-5978

$42.93

Get Your Coupon 49 more results found for HEALTH MART ATLAS 630

ECHO CARE SPECIALTY PHARMACY

260 Broadway
Brooklyn NY 11211
(718)782-3030

$42.93

Get Your Coupon

APICHA HEALTH CENTER PHARMACY

400 Broadway
New York NY 10013
(844)370-6202

$47.93

Get Your Coupon 4 more results found for MAXORXPRESS

CHELSEA ROYAL CARE PHARMACY, INC.

154 9 Th Ave
New York NY 10011
(212)255-8000

$47.93

Get Your Coupon

CHRONOS PHARMACY

30 96 36 Th Street
Astoria NY 11103
(718)932-8700

$47.93

Get Your Coupon

COLUMBIA DRUGS

55 Columbia St
New York NY 10002
(212)533-8120

$47.93

Get Your Coupon

CONTIGO PHARMACY

3510 Bergenline Ave
Union City NJ 07087
(201)500-9366

$47.93

Get Your Coupon 18 more results found for GERIMED LTC NETWORK INC

ROR MADISON PHARMACY INC

1636 Madison Ave
New York NY 10029
(212)369-0700

$47.93

Get Your Coupon

RX CENTER

2325 1 St Ave
New York NY 10035
(212)289-8839

$47.93

Get Your Coupon

ST JOHNS PHARMACY

2980 John F Kennedy Blvd
Jersey City NJ 07306
(201)963-3617

$47.93

Get Your Coupon

TURTLE BAY CHEMISTS

901 2 Nd Ave
New York NY 10017
(212)752-5151

$47.93

Get Your Coupon

UMR PHARMACY & SURGICAL INC

437 Central Ave
Jersey City NJ 07307
(201)418-0009

$47.93

Get Your Coupon

CARE PLUS CVS/PHARMACY #02546

1200 Harbor Blvd
Weehawken NJ 07086
(201)330-8147

$54.37

Get Your Coupon 77 more results found for CVS PHARMACY INC

CVS PHARMACY # 17820

10 Union Sq E
New York NY 10003
(212)895-9917

$54.37

Get Your Coupon 7 more results found for CVS PHARMACY IN TARGET

CVS PHARMACY #02919

126 Eighth Ave
New York NY 10011
(800)362-7828

$54.37

Get Your Coupon

WALMART PHARMACY 10-3520

400 Park Place
Secaucus NJ 07094
(201)325-9275

$64.85

Get Your Coupon 1 more results found for WALMART STORES INC

Pregnancy

8.1 Pregnancy Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Therefore, Clobetasol propionate cream, 0.05% (emollient) should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels. Some corticosteroids have been shown to be teratogenic after dermal application to laboratory animals. Clobetasol propionate has not been tested for teratogenicity by this route; however, it is absorbed percutaneously, and when administered subcutaneously it was a significant teratogen in both the rabbit and mouse. Clobetasol propionate has greater teratogenic potential than steroids that are less potent. Teratogenicity studies in mice using the subcutaneous route resulted in fetotoxicity at the highest dose tested (1 mg/kg) and teratogenicity at all dose levels tested down to 0.03 mg/kg. These doses are approximately 0.33 and 0.01 times, respectively, the human topical dose of Clobetasol propionate cream, 0.05% (emollient). Abnormalities seen included cleft palate and skeletal abnormalities. In rabbits, clobetasol propionate was teratogenic at doses of 3 and 10 mcg/kg. These doses are approximately 0.001 and 0.003 times, respectively, the human topical dose of Clobetasol propionate cream, 0.05% (emollient). Abnormalities seen included cleft palate, cranioschisis, and other skeletal abnormalities.

Indications And Usage

1 INDICATIONS AND USAGE Clobetasol propionate cream, 0.05% (emollient) is a corticosteroid indicated for: •The relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 12 years of age or older. (1.1) •The treatment of moderate to severe plaque-type psoriasis in patients 16 years of age and older. (1.2) Limitations of Use •Clobetasol propionate cream, 0.05% (emollient) should not be used in the treatment of rosacea or perioral dermatitis, and should not be used on the face, groin, or axillae. (1.3) •The total dosage should not exceed 50 grams per week.(1.3) •Avoid use if skin atrophy is present at the treatment site.(1.3) Clobetasol propionate cream, 0.05% (emollient) is a super-high potency corticosteroid indicated for: 1.1 Corticosteroid-Responsive Dermatoses Clobetasol propionate cream, 0.05% (emollient) is indicated for the relief of the inflammatory and pruritic manifestations of cortico-steroid-responsive dermatoses in patients 12 years of age and older. Treatment should be limited to 2 consecutive weeks, and the total dosage should not exceed 50 grams per week. 1.2 Moderate to Severe Plaque-Type Psoriasis Clobetasol propionate cream, 0.05% (emollient) is indicated for the topical treatment of moderate to severe plaque-type psoriasis. Treatment beyond 4 consecutive weeks is not recommended. Use in pediatric patients under 16 years of age is not recommended. 1.3 Limitations of Use Clobetasol propionate cream, 0.05% (emollient) should not be used in the treatment of rosacea or perioral dermatitis, and should not be used on the face, groin, or axillae. The total dosage should not exceed 50 grams per week. Avoid use if skin atrophy is present at the treatment site.

Clinical Studies

14 CLINICAL STUDIES In a controlled clinical trial involving patients with moderate to severe plaque-type psoriasis, Clobetasol propionate cream, 0.05% (emollient) was applied to 5% to 10% of body surface area. In this trial, there were no clobetasol-treated patients with clinically significant decreases in morning cortisol levels after 4 weeks of treatment; however, morning cortisol levels may not identify patients with adrenal dysfunction.

Warnings And Cautions

5 WARNINGS AND PRECAUTIONS •Clobetasol propionate is a highly potent topical corticosteroid that has been shown to suppress the HPA axis doses as low as 2 grams per day. (5.1) •Cushing's syndrome, hyperglycemia, and glucosuria can also result from systemic absorption of topical corticosteroids. (5.1) •Systemic absorption may require periodic evaluation for HPA axis suppression. Modify use if HPA axis suppression develops. (5.1) •Children may be more susceptible to systemic toxicity from use of topical corticosteroids. (5.1, 8.4) •Local adverse reactions with topical corticosteroids may occur more frequently with the use of occlusive dressings and higher potency corticosteroids, including clobetasol propionate. These reactions include: folliculitis, acneiform eruptions, hypertrichosis, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infection, striae and miliaria. (5.2) 5.1 Effects on the Endocrine System Clobetasol propionate is a highly potent topical corticosteroid that has been shown to suppress the HPA axis at doses as low as 2 grams per day. Systemic absorption of topical corticosteroids can produce reversible HPA axis suppression with the potential for clinical glucocorticosteroid insufficiency. This may occur during treatment or upon withdrawal of the topical corticosteroid. Because of the potential for systemic absorption, use of topical corticosteroids may require that patients be periodically evaluated for HPA axis suppression. In a study including 12 subjects ages 18 years and older with psoriasis or atopic dermatitis involving at least 30% body surface area (BSA), adrenal suppression was identified in 3 out of 12 subjects (25%) following 1 week of treatment. Factors that predispose a patient using a topical corticosteroid to HPA axis suppression include the use of more potent steroids, use over large surface areas, use over prolonged periods, use under occlusion, use on an altered skin barrier, and use in patients with liver failure. An ACTH stimulation test may be helpful in evaluating patients for HPA axis suppression. If HPA axis suppression is documented, an attempt should be made to gradually withdraw the drug, to reduce the frequency of application, or to substitute a less potent steroid. Manifestations of adrenal insufficiency may require supplemental systemic corticosteroids. Recovery of HPA axis function is generally prompt and complete upon discontinuation of topical corticosteroids. Cushing's syndrome, hyperglycemia, and unmasking of latent diabetes mellitus can also result from systemic absorption of topical corticosteroids. Use of more than one corticosteroid-containing product at the same time may increase the total systemic corticosteroid exposure. Pediatric patients may be more susceptible to systemic toxicity from use of topical corticosteroids. [see Use in Specific Populations (8.4) ] 5.2 Local Adverse Reactions with Topical Corticosteroids Local adverse reactions may be more likely to occur with occlusive use, prolonged use or use of higher potency corticosteroids. Reactions may include atrophy, striae, telangiectasias, burning, itching, irritation, dryness, folliculitis, acneiform eruptions, hypopigmentation, hypertrichosis, perioral dermatitis, allergic contact dermatitis, secondary infection, and miliaria. Some local adverse reactions may be irreversible. Clobetasol propionate is not recommended in patients with acne vulgaris, rosacea or perioral dermatitis. 5.3 Allergic Contact Dermatitis Allergic contact dermatitis with corticosteroids is usually diagnosed by observing a failure to heal rather than noting a clinical exacerbation. Clinical diagnosis of allergic contact dermatitis can be confirmed with patch testing. If irritation develops, Clobetasol propionate cream, 0.05% (emollient) should be discontinued and appropriate therapy instituted. 5.4 Concomitant Skin Infections If concomitant skin infections are present or develop, an appropriate antifungal or antibacterial agent should be used. If a favorable response does not occur promptly, use of Clobetasol propionate cream, 0.05% (emollient) should be discontinued until the infection has been adequately controlled.

Overdosage

10 OVERDOSAGE Topically applied Clobetasol propionate cream, 0.05% (emollient) can be absorbed in sufficient amounts to produce systemic effects [see Warnings and Precautions (5.1) ].

Adverse Reactions

6 ADVERSE REACTIONS •The most common adverse reaction is burning/stinging (incidence 5%); common adverse reactions (incidence < 2%) are pruritis, irritation, erythema, folliculitis, cracking and fissuring of the skin, numbness of the fingers, tenderness in the elbow, skin atrophy, and telangiectasia. (6.1). To report SUSPECTED ADVERSE REACTIONS, contact Fougera Pharmaceuticals Inc. at 1-800-645-9833 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice. In controlled trials with clobetasol propionate formulations, the following adverse reactions have been reported: burning/stinging, pruritis, irritation, erythema, folliculitis, cracking and fissuring of the skin, numbness of the fingers, tenderness in the elbow, skin atrophy, and telangiectasia. The incidence of local adverse reactions reported in the trials with Clobetasol propionate cream, 0.05% (emollient) was less than 2% of patients treated with the exception of burning/stinging which occurred in 5% of treated patients.

Mechanism

12.1 Mechanism of Action Like other topical corticosteroids, clobetasol propionate has anti-inflammatory, antipruritic, and vasoconstrictive properties. The mechanism of the anti-inflammatory activity of the topical steroids, in general, is unclear. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2.

Contraindications

4 CONTRAINDICATIONS None None (4)

Nursing Mothers

8.3 Nursing Mothers Systemically administered corticosteroids appear in human milk and could suppress growth, interfere with endogenous corticosteroid production, or cause other untoward effects. It is not known whether topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in human milk. Because many drugs are excreted in human milk, caution should be exercised when Clobetasol propionate cream, 0.05% (emollient) is administered to a nursing woman.